Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 101,084 | 488,668 | 244,674 | 29,076 | 24,043 |
| Marketable Securities | 108,684 | 70,773 | 27,263 | 37,737 | 62,106 |
| Receivables | 78,045 | 32,108 | 22,275 | 13,692 | 12,555 |
| Inventories | 10,494 | 8,456 | 10,145 | 9,587 | 5,395 |
| Income taxes - deferred | N/A | 9,601 | 26,860 | N/A | N/A |
| TOTAL | $308,972 | $617,620 | $337,045 | $95,267 | $109,489 |
| Non-Current Assets | |||||
| PPE Net | 14,794 | 7,055 | 8,340 | 8,237 | 1,070 |
| Investments And Advances | 0 | 6,961 | 4,080 | 11,079 | 53,644 |
| Intangibles | 1,008,994 | 72,361 | 82,521 | 25,078 | 0 |
| Other Non-Current Assets | 24,489 | 7,068 | 76,667 | 1,992 | 169 |
| TOTAL | $1,048,277 | $93,445 | $171,608 | $46,386 | $54,883 |
| Total Assets | $1,357,249 | $711,065 | $508,653 | $141,653 | $164,372 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 31,477 | 19,659 | 34,935 | 32,578 | 26,784 |
| Accrued Expenses | 183,989 | 35,710 | N/A | N/A | N/A |
| Other current liabilities | 4,166 | 2,130 | 57,006 | 830 | 64 |
| TOTAL | $219,632 | $57,499 | $156,857 | $36,681 | $39,840 |
| Non-Current Liabilities | |||||
| Long Term Debt | 563,012 | N/A | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | 3,041 | 3,273 | 12,992 |
| Other Non-Current Liabilities | 259,550 | 256,530 | 201,905 | 5,520 | 682 |
| TOTAL | $822,562 | $289,119 | $214,380 | $21,036 | $18,614 |
| Total Liabilities | $1,042,194 | $346,618 | $371,237 | $57,717 | $58,454 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,016 | 993 | 944 | 942 | 926 |
| Common Shares | 264,511 | 239,961 | 221,124 | 211,266 | 203,511 |
| Retained earnings | -28,024 | 47,714 | -84,048 | -127,361 | -97,580 |
| Other shareholders' equity | -54 | -37 | -7 | 31 | -13 |
| TOTAL | $315,055 | $364,447 | $137,416 | $83,936 | $105,918 |
| Total Liabilities And Equity | $1,357,249 | $711,065 | $508,653 | $141,653 | $164,372 |